Healthcare -
Biotechnology - NASDAQ - US
$ 0.82
0.737 %
$ 3.53 M
Market Cap
-0.1
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
27.04%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Bio-Path Holdings, Inc.
BPTH has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart BPTH
EBIT FORECAST
EBIT Forecast Chart BPTH
NET INCOME FORECAST
Net Income Chart BPTH